Cargando…

Akt methylation by SETDB1 promotes Akt kinase activity and oncogenic functions

Aberrant activation of Akt disturbs proliferation, survival and metabolic homeostasis of various human cancers. Thus, it is critical to understand upstream signaling pathways governing Akt activation. Here, we report that Akt undergoes SETDB1-mediated lysine-methylation to promote its activation, wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jianping, Dai, Xiangpeng, Laurent, Benoit, Zheng, Nana, Gan, Wenjian, Zhang, Jian, Guo, Ailan, Yuan, Min, Liu, Pengda, Asara, John M., Toker, Alex, Shi, Yang, Pandolfi, Pier Paolo, Wei, Wenyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377565/ https://www.ncbi.nlm.nih.gov/pubmed/30692625 http://dx.doi.org/10.1038/s41556-018-0261-6

Ejemplares similares

SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions
por: Jiang, Qiwei, et al.
Publicado: (2021)

Copper Promotes Tumorigenesis by Activating the PDK1‐AKT Oncogenic Pathway in a Copper Transporter 1 Dependent Manner
por: Guo, Jianping, et al.
Publicado: (2021)

Dual phosphorylation of Sin1 at T86 and T398 negatively regulates mTORC2 complex integrity and activity
por: Liu, Pengda, et al.
Publicado: (2014)

S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions
por: Jiang, Qiwei, et al.
Publicado: (2022)

SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis
por: Wang, Guihua, et al.
Publicado: (2019)

PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis
por: Yin, Shasha, et al.
Publicado: (2021)

TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway
por: Gu, Hongyu, et al.
Publicado: (2022)

LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
por: Gan, Wenjian, et al.
Publicado: (2020)

Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer
por: Nishikawaji, Taketo, et al.
Publicado: (2016)

Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signaling to suppress tumorigenesis
por: Liu, Pengda, et al.
Publicado: (2013)

Genetic fusions favor tumorigenesis through degron loss in oncogenes
por: Liu, Jing, et al.
Publicado: (2021)

SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway
por: Han, Shuai, et al.
Publicado: (2020)

Retraction Note: SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway
por: Han, Shuai, et al.
Publicado: (2022)

Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis
por: Mancini, Maria L., et al.
Publicado: (2016)

Glutathione biosynthesis is a metabolic vulnerability in PI3K/Akt-driven breast cancer
por: Lien, Evan C., et al.
Publicado: (2016)

Protein Tyrosine Kinase 6 Protects Cells from Anoikis by Directly Phosphorylating Focal Adhesion Kinase and Activating AKT
por: Zheng, Yu, et al.
Publicado: (2012)

Acetylation-dependent regulation of BRAF oncogenic function
por: Dai, Xiangpeng, et al.
Publicado: (2022)

SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway
por: Liu, Jia, et al.
Publicado: (2014)

Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
por: Mu, Guangfu, et al.
Publicado: (2020)

SETDB1 Is Involved in Postembryonic DNA Methylation and Gene Silencing in Drosophila
por: Gou, Dawei, et al.
Publicado: (2010)

SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation
por: Qian, Xiaoli, et al.
Publicado: (2023)

PH domain-mediated autoinhibition and oncogenic activation of Akt
por: Bae, Hwan, et al.
Publicado: (2022)

Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo
por: Hashimoto, M, et al.
Publicado: (2013)

Retraction: SETDB1 Is Involved in Postembryonic DNA Methylation and Gene Silencing in Drosophila
Publicado: (2018)

What Does the “AKT” Stand for in the Name “AKT Kinase”? Some Historical Comments
por: Xie, Jiuyong, et al.
Publicado: (2020)

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
por: Federico, Aniello, et al.
Publicado: (2020)

Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study
por: Zhong, Sheng, et al.
Publicado: (2022)

SETDB1-Mediated Silencing of Retroelements
por: Fukuda, Kei, et al.
Publicado: (2020)

SETDB1 regulates microtubule dynamics
por: Hernandez‐Vicens, Rosari, et al.
Publicado: (2022)

SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
por: She, Xiaowei, et al.
Publicado: (2023)

Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling
por: Beckham, T H, et al.
Publicado: (2013)

The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
por: Shoji, K, et al.
Publicado: (2009)

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
por: Brastianos, Priscilla K., et al.
Publicado: (2013)

Hepatocellular SETDB1 Regulates Hepatic Ischemia-Reperfusion Injury through Targeting Lysine Methylation of ASK1 Signal
por: Xia, Kang, et al.
Publicado: (2023)

Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations
por: Lee, Jii Bum, et al.
Publicado: (2021)

Glycogen synthase kinase 3 drives thymocyte egress by suppressing β-catenin activation of Akt
por: Liu, Chenfeng, et al.
Publicado: (2021)

Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2
por: Wang, Zhiwei, et al.
Publicado: (2012)

MOB kinase activator 1A acts as an oncogene by targeting PI3K/AKT/mTOR in ovarian cancer
por: Lei, Jian, et al.
Publicado: (2023)

Rab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway
por: Guo, Bo, et al.
Publicado: (2017)

Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
por: Torrano, Joachim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cbnabv7sakmb64jgg6873rlgdg